Evidence map›Paper›PMID 25757160›Full record

ArticleDNA and cell biology2015

Enhancement of the TCRζ expression, polyclonal expansion, and activation of t cells from patients with acute myeloid leukemia after IL-2, IL-7, and IL-12 induction.

Li Shi, Shaohua Chen, Xianfeng Zha, Yan Xu, Ling Xu, Lijian Yang, Yuhong Lu, Kanger Zhu, Yangqiu Li

Open access · greenAbstract read
In one paragraph

Article in DNA and cell biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. HighFrontiers in immunology · 2022
    Article
  4. Article
  5. Higher PD-1 expression concurrent with exhausted CD8+ T cells in patients withChinese journal of cancer research = Chung-kuo yen cheng yen chiu · 2017
    Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Li Shi1 Institute of Hematology, Jinan University , Guangzhou, China .
Shaohua Chen1 Institute of Hematology, Jinan University , Guangzhou, China .
Xianfeng Zha2 Department of Clinical Laboratory, First Affiliated Hospital, Jinan University , Guangzhou, China .
Yan Xu1 Institute of Hematology, Jinan University , Guangzhou, China .
Ling Xu1 Institute of Hematology, Jinan University , Guangzhou, China .
Lijian Yang1 Institute of Hematology, Jinan University , Guangzhou, China .
Yuhong Lu4 Department of Hematology, First Affiliated Hospital, Jinan University , Guangzhou, China .
Kanger Zhu4 Department of Hematology, First Affiliated Hospital, Jinan University , Guangzhou, China .
Yangqiu Li1 Institute of Hematology, Jinan University , Guangzhou, China .
Jinan University · CNFirst Affiliated Hospital of Jinan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Defective T cell receptor (TCR) signaling resulting in lower T cell function plays a crucial role in the pathogenesis of T cell immunodeficiency in leukemia. Previous studies have indicated that lower TCRζ levels are a common characteristic of patients with leukemia, and upregulating TCRζ could partially recover T cell function. In this study, we characterized the effect of the stimulating factor induction on the TCRζ, Zap-70, and FcɛRIγ levels, IFN-γ secretion, and the distribution and clonal expansion of TCR Vβ subfamilies in CD3(+) T cells sorted from peripheral blood from acute myeloid leukemia (AML) patients. The induction included single stimulating factor or a combination with different cytokines (IL-2, IL-7, IL-2+IL-7, IL-7+IL-12, CD3, CD3+CD28 antibody, CD3+CD28 antibody+IL-2, and CD3+CD28 antibody+IL-7) at 72 h. The results showed that increased TCRζ and Zap-70 levels with deceased FcɛRIγ in T cells after induction, and different responses to cytokine in T cell from different cases may indicate the heterogeneity of T cells and different immune statuses in different AML cases. Increased IFN-γ levels in T cells from AML patients were detected after induction in the IL-12+IL-7, CD3+CD28+IL-2, and CD3+CD28+IL-7 groups. Moreover, the number of TCR Vβ subfamily T cells expressed was increased; however, all of the TCR Vβ subfamily T cells in the AML patients could not be completely recovered after induction. In conclusion, the cytotoxicity and activation function of T cells could be enhanced after induction by different stimuli accompanied by an increase in TCRζ and Zap-70 and recovery of the TCR Vβ repertoire in AML patients.

Indexed as

AdolescentAdultCell ProliferationCells, CulturedFemaleHumansInterferon-gammaInterleukin-12Interleukin-2Interleukin-7Leukemia, Myeloid, AcuteLymphocyte ActivationMaleMiddle AgedReceptors, Antigen, T-CellReceptors, IgEantigen T cell receptor, zeta chainInterferon-gammaInterleukin-12Interleukin-2Interleukin-7Receptors, Antigen, T-CellReceptors, IgEZAP-70 Protein-Tyrosine Kinase

Identifiers

PMID25757160
PMCPMC4504257
OpenAlexW1929096810

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.